James Douglas Hunter
Plus aucun poste en cours
Profil
James Douglas Hunter served as Secretary, Director & Finance Director at Proximagen Group Plc from 2010 to 2012.
He was a Director at Minster Pharmaceuticals Plc.
From 2014 to 2016, he served as CFO, Secretary & Executive Director at Venture Life Group Plc.
Mr. Hunter holds an MBA from Cranfield School of Management.
Anciens postes connus de James Douglas Hunter
| Sociétés | Poste | Fin |
|---|---|---|
| VENTURE LIFE GROUP PLC | Directeur Financier/CFO | 30/11/2016 |
Minster Pharmaceuticals Plc
 Minster Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Minster Pharmaceuticals Plc develops pharmaceutical compounds for the treatment of neurological and psychiatric conditions. The company operates in Tonabersat and Sabcomeline segments. The Tonabersat segment is for the prevention and treatment of migraine. The Sabcomeline segment is for the management of cognitive decline and negative symptoms in schizophrenia. Minster Pharmaceuticals was founded by Robert Stubbs and Paul Sharpe in 2001 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Proximagen Group Plc
 Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Directeur Financier/CFO | - |
Formation de James Douglas Hunter
| Cranfield School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VENTURE LIFE GROUP PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Minster Pharmaceuticals Plc
Minster Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Minster Pharmaceuticals Plc develops pharmaceutical compounds for the treatment of neurological and psychiatric conditions. The company operates in Tonabersat and Sabcomeline segments. The Tonabersat segment is for the prevention and treatment of migraine. The Sabcomeline segment is for the management of cognitive decline and negative symptoms in schizophrenia. Minster Pharmaceuticals was founded by Robert Stubbs and Paul Sharpe in 2001 and is headquartered in London, the United Kingdom. | Health Technology |
